Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040611 | SCV000064302 | benign | not specified | 2021-01-26 | criteria provided, single submitter | clinical testing | The p.Arg22681Cys variant in TTN is classified as benign because it has been identified in 0.65% (200/30564) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Eurofins Ntd Llc |
RCV000040611 | SCV000335465 | benign | not specified | 2015-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000535856 | SCV000643672 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001719775 | SCV000719146 | likely benign | not provided | 2019-01-02 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171267 | SCV001333976 | benign | Cardiomyopathy | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839693 | SCV002100199 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839694 | SCV002100200 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839695 | SCV002100201 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839692 | SCV002100203 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001719775 | SCV005040977 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | TTN: BS2 |
Clinical Genetics, |
RCV000040611 | SCV001923550 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000040611 | SCV001930935 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001719775 | SCV001968787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541176 | SCV004782715 | likely benign | TTN-related disorder | 2019-04-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |